Knowledge

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:

Publications

Hogan Lovells Publications

Podcast: Talking the cure

Our team is always thinking about how to conquer and foresee the most significant industry issues facing our clients. Over the next year, we will touch on cutting-edge topics such as...

Hogan Lovells Publications

Life sciences and health care horizons 2021

Companies in the life sciences and health care industry navigated unparalleled challenges in 2020. The pandemic forced the development and adoption of new technologies and innovations...

News

Looking ahead to 2021: AI – A brave new world?

In recent years, AI has become a buzzword in life sciences and health care as the technology has developed to create applications from drug discovery to diagnostics to therapeutics. Most...

News

DABUS and the dawn of AI inventors: “the topic that patent lawyers should be monitoring”

In a recent Managing IP article, Imogen Ireland and Jason Lohr examined the recent decisions on “DABUS” to show why AI inventors are not just a future problem

Insights

AI and Drug Development: IP and data protection challenges - Webinar recording
Registered Content

On Tuesday 19 November, a panel from our London life sciences team presented a webinar on what you need to know when using AI tools in drug development, in order to best...

Hogan Lovells Publications

View from the Horizon: Artificial Intelligence and Cannabusiness in London

On May 16 the second edition of our new global series, Life Sciences and Health Care Horizons, took place in London featuring two panel discussions that focused on the challenges and...

News

Life Sciences and Health Care Horizons 2019 publication: IP in the mix

Innovation in the life sciences and health care industries is occurring at a dizzying pace. Five years ago, anti-PD-1 antibodies from Merck and BMS had yet to be approved, CAR-T therapies ...

News

The Skilled Machines Disrupting Drug Design

Capable of identifying novel compounds for therapeutic use, AI is saving time and costs in a process that can take around 10 to 15 years and billions of pounds to complete.

News

EU Patent Office publishes preview of guidelines on patenting AI applications

Earlier this year the European Patent Office (“EPO”) held its first ever conference on patenting artificial intelligence (“AI”). Following intensive discussions on...

Loading data